to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
In perusing last week's headlines (and a few stragglers from the week prior), I realized I was drawn to numerous articles pertaining to entrepreneurial support beyond that in the United States. For those who don't know, my work at Kauffman allows me to travel a bit--about 100,000 miles a year to be exact.
Entrepreneurship is vision and values but, on eVenturing at least, it's also "tools and templates." These are those practical agreements, models, checklists, samples, worksheets, and other items so vital to the day-to-day operation and success of your company. The monthly Collections provide them by topic-and we keep track of how much attention they get. Listed here are the tools and templates most viewed by your fellow entrepreneurs from September 2006 to September 2007. We assume that means your peers found value in them, and that there's a good chance you will, too.
Investors write checks because they hope to get a decent return on their money. The way venture capitalists reap those returns is by taking their companies public, or perhaps selling them to other companies. That's a tough game when demand for IPOs is anemic, as it was in 2009.
Demand hasn't been robust in 2010, but things are thawing. As of this writing, eight companies had done IPOs thus far this year--the same amount for all of last year, according to CB Insights, a Manhattan firm that tracks private-company funding trends (including venture capital, private equity and government-backed deals).
"The venture funding and M&A activity we've observed so far in 2010 suggests that this year's venture funding levels will be higher than last year, but still below those highs of a few years ago," says Anand Sanwal, a CB Insights founding partner.
Biotech entrepreneurs face unique business challenges in bringing their products to market. To partner effectively in the biotech space, this question-and-answer article identifies key tasks, including advice on term sheets, intellectual property protection, and treatment of royalties.
Really about the top ten "legal" mistakes startup entrepreneurs make, this piece offers practical, important tips on doing things right the first time to avoid costly legal rework later. Must-read information for founders who think "legal" can be dealt with "later."
With 2012 now in the rearview mirror, we take a look at the most popular PDE posts at entrepreneurship.org. Global content dominates the top of the list with six of the ten posts covering Africa, Brazil, Canada, Chile, the United Kingdom and a global ranking of the top startup ecosystems.
Always: too much information, not enough time. This list can pare your blogging time be recommending blogs that are worth your valuable time.
Well-known and well-published futurist Dr. James Canton predicts that the real-time economy of the 21st century will reveal IT as the primary enabling force driving competitive advantage. Check out Dr. Canton's top 10 IT trends for 2007.
Entrepreneur and business model innovator Alexander Osterwalder discusses dynamic, yet simple-to-use tools for visualizing, challenging and re-inventing business models. Osterwalder articulates how to use the visual language of his business model canvas framework, and shares stories of how this approach helps organizations of all sizes to better create, deliver and capture value.
Leaders of biotech companies and other life science businesses need to keep their speeches focused and light on the science. Read more about this and other tips for giving great speeches to investors or anyone else.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.